Članki z zahtevami za javni dostop - paul klenermanVeč o tem
SkupnoWellcomeNIHRMRCNIHUK Research & InnovationCancer Research UKBBSRCDFGEuropean CommissionGatesBHFSNSFNHMRCRoyal Society UKEPSRCHRBARCHealth Data Research, UKCIHRHHMINSFCRCNGovernment of ItalyINSERMVersus Arthritis, UKDFIDGovernment of SpainBlood Cancer UKDoDGenome CanadaNWOA*StarDMTParkinson's UKBMBFACLFWFSFISwedish Research CouncilNRFKWFArnold Ventures LLCUSAIDNSERCEMBLHelmholtzDCTIHEADSTFCTAcademy of Medical Sciences, UKCSOFondazione CariploZonMwANRKNAWSCFDHFNMRCJDRFMQ Mental Health ResearchCoeliac UKEDCTP
Ni na voljo nikjer: 13
T cell responses to cytomegalovirus
P Klenerman, A Oxenius
Nature Reviews Immunology 16 (6), 367-377, 2016
Zahteve: Swiss National Science Foundation, US National Institutes of Health, UK …
Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa
PC Matthews, AM Geretti, PJR Goulder, P Klenerman
Journal of clinical virology 61 (1), 20-33, 2014
Zahteve: National Institute for Health Research, UK, Wellcome Trust
T cell responses in hepatitis C: the good, the bad and the unconventional
P Klenerman, R Thimme
Gut 61 (8), 1226-1234, 2012
Zahteve: US National Institutes of Health, German Research Foundation
Hepatitis C vaccine: supply and demand
GT Strickland, SS El-Kamary, P Klenerman, A Nicosia
The Lancet Infectious Diseases 8 (6), 379-386, 2008
Zahteve: US National Institutes of Health
Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis
D Capraru, A Müller, E Csernok, WL Gross, K Holl-Ulrich, J Northfield, ...
Clinical immunology 127 (2), 144-150, 2008
Zahteve: German Research Foundation
Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154
M Mueller, HC Spangenberg, N Kersting, T Altay, HE Blum, P Klenerman, ...
Journal of hepatology 52 (6), 800-811, 2010
Zahteve: German Research Foundation
T‐and B‐cell responses and previous exposure to hepatitis B virus in ‘anti‐HB c alone’patients
Q Wang, P Sachse, M Semmo, M Lokhande, M Montani, JF Dufour, ...
Journal of viral hepatitis 22 (12), 1068-1078, 2015
Zahteve: National Natural Science Foundation of China, National Institute for Health …
Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany
H Komatsu, P Klenerman, R Thimme
Hepatology Research 50 (3), 272-282, 2020
Zahteve: National Institute for Health Research, UK, Wellcome Trust
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID‐19 cohort
N Shah, B Xue, Z Xu, H Yang, E Marwali, H Dalton, PPR Payne, C Lu, ...
Artificial Organs 47 (9), 1490-1502, 2023
Zahteve: Bill & Melinda Gates Foundation, US National Institutes of Health …
Integrated species-level analysis of metagenome and inflammatory mediators reveals dominant and distinct roles of haemophilus influenzae and moraxella catarrhalis in severe asthma
MF Jabeen, ND Sanderson, M Tinè, G Donachie, CGM Barber, A Azim, ...
Zahteve: UK Medical Research Council, National Institute for Health Research, UK …
Understanding Liver Transplantation Outcomes Through the Lens of Its Tissue-resident Immunobiome
AC Prosser, P Klenerman, M Lucas
Transplantation, 10.1097, 2025
Zahteve: Wellcome Trust
Adenovirus vector and mRNA vaccines
NM Provine, P Klenerman
European Journal of Immunology 53 (6), 2023
Zahteve: National Institute for Health Research, UK, Wellcome Trust
Early and non-reversible decrease of CD161++/mucosal associated invariant T cells in HIV infection
C Cosgrove, JE Ussher, A Rauch, K Gärtner, A Kurioka, MH Hühn, ...
Journal of Infection 67 (4), 342-343, 2013
Zahteve: US National Institutes of Health, Wellcome Trust
Na voljo nekje: 488
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
Zahteve: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
Zahteve: US National Institutes of Health, UK Engineering and Physical Sciences …
The human cell atlas
A Regev, SA Teichmann, ES Lander, I Amit, C Benoist, E Birney, ...
elife 6, e27041, 2017
Zahteve: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
Zahteve: Swiss National Science Foundation, US National Institutes of Health, Genome …
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
Zahteve: Swiss National Science Foundation, US National Institutes of Health, UK …
Genetic mechanisms of critical illness in COVID-19
E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ...
Nature 591 (7848), 92-98, 2021
Zahteve: Bill & Melinda Gates Foundation, Health Research Board, Ireland, UK …
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
Zahteve: Bill & Melinda Gates Foundation, UK Medical Research Council, National …
Podatke o objavi in financiranju samodejno določi računalniški program